Home
>
National Drug Code (NDC)
>
Moexipril hydrochloride/hydrochlorothiazide
Moexipril hydrochloride/hydrochlorothiazide - 16252-614-01 - (Moexipril hydrochloride and hydrochlorothiazide)
Drug Information of Moexipril hydrochloride/hydrochlorothiazide
| Product NDC: | 16252-614 |
| Proprietary Name: | Moexipril hydrochloride/hydrochlorothiazide |
| Non Proprietary Name: | Moexipril hydrochloride and hydrochlorothiazide |
| Active Ingredient(s): | 25; 15 mg/1; mg/1 & nbsp; Moexipril hydrochloride and hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Moexipril hydrochloride/hydrochlorothiazide
| Product NDC: | 16252-614 |
| Labeler Name: | Cobalt Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020729 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070315 |
Package Information of Moexipril hydrochloride/hydrochlorothiazide
| Package NDC: | 16252-614-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (16252-614-01) |
NDC Information of Moexipril hydrochloride/hydrochlorothiazide
| NDC Code | 16252-614-01 |
| Proprietary Name | Moexipril hydrochloride/hydrochlorothiazide |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (16252-614-01) |
| Product NDC | 16252-614 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Moexipril hydrochloride and hydrochlorothiazide |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070315 |
| Marketing Category Name | NDA |
| Labeler Name | Cobalt Laboratories |
| Substance Name | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE |
| Strength Number | 25; 15 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
